Guidance Archives - Page 613 of 637

2 minute read

Why These Paymentus Analysts Are Lowering Price Targets After Q2 Earnings

August 4, 3:46 PM

Cloud based bill payment company Paymentus Holdings (NYSE: PAY) saw shares fall after reporting second-quarter financial results after the market close Wednesday. Analysts are sizing up the company’s guidance and contract delays.

PAY

1 minute read

Bombardier Reports Q2 Results, Raises FY22 FCF Guidance

By Akanksha Bakshi

August 4, 3:41 PM

Bombardier Inc. (OTC:BDRAF) reported second-quarter revenues of $1.6 billion, an increase of 2% year-over-year, reflecting 28 aircraft deliveries and a 22%…

BDRAF

1 minute read

Vulcan Materials Shares Gain After Q2 Results

By Akanksha Bakshi

August 4, 2:19 PM

Vulcan Materials Co (NYSE:VMC) reported a second-quarter revenue increase of 43.6% year-over-year to $1.95 billion, beating the consensus of $1.86…

VMC

1 minute read

Wrangler, Lee Parent Posts Mixed Q2 Earnings

By Shivani Kumaresan

August 4, 1:54 PM

Kontoor Brands Inc (NYSE:KTB) reported second-quarter FY22 sales growth of 25.1% year-on-year to $614 million, missing the consensus of $618.20 million.…

KTB

1 minute read

Crocs Shares Drop On Gloomy Outlook; Q2 Earnings Top Estimates

By Shivani Kumaresan

August 4, 1:17 PM

Crocs Inc (NASDAQ:CROX) reported second-quarter FY22 sales growth of 50.5% year-on-year to $964.58 million, beating the consensus of $937.44 million. Wholesale…

CROX

1 minute read

Quanta Services Shares Down After Q2 Results, Narrows FY22 EPS Forecast

By Akanksha Bakshi

August 4, 12:42 PM

Quanta Services Inc (NYSE:PWR) reported second-quarter revenue growth of 41.1% year-over-year to $4.23 billion, beating the consensus of $4.04 billion.…

PWR

1 minute read

Zoetis’s Clocks Mixed Q2 Earnings, Lowers FY22 Profit Outlook

By Vandana Singh

August 4, 12:23 PM

Zoetis Inc (NYSE: ZTS) has reported Q2 FY22 revenue of $2.05 billion, an increase of 5% Y/Y, almost in line with…

ZTS

2 minute read

FDA Lifts Clinical Hold On BioCryst’s BCX9930 Program For Rare Blood Disorder

By Vandana Singh

August 4, 12:11 PM

The FDA lifted a partial clinical hold on BioCryst Pharmaceuticals Inc’s (NASDAQ:BCRX) BCX9930 program. The company will resume enrollment under revised protocols…

BCRX

1 minute read

Iron Mountain Clocks 15% Revenue Growth In Q2 Backed By Storage, Service Revenue; Reiterates FY22 Outlook

By Anusuya Lahiri

August 4, 12:10 PM

Iron Mountain Inc (NYSE:IRM) reported second-quarter FY22 revenue growth of 15% year-on-year to $1.29 billion, marginally missing the consensus of $1.30…

IRM

1 minute read

Read How Penn National Gaming Fared In Q2

By Shivani Kumaresan

August 4, 11:57 AM

Penn National Gaming Inc (NASDAQ:PENN) reported second-quarter FY22 sales growth of 5.2% year-on-year to $1.63 billion, beating the consensus of $1.61…

PENN